Tag: AI Drug Discovery
India puts 86 crore behind four AI designed drug candidates
India's Technology Development Board approved 86 crore rupees of support for Peptris, which will push four AI-discovered molecules into preclinical…
AstraZeneca signs an AI discovery pact worth up to $1.5B
AstraZeneca has signed a multi-year drug-discovery collaboration with the AI biotech insitro, a deal the companies value at up to…
Insilico nominates an AI-designed obesity pill with a safety edge
The Hong Kong-listed biotech used its generative chemistry platform to design ISM1354, a small-molecule GIPR antagonist built for obesity and…
Four pharma giants pool antibodies to train a developability AI
AbbVie, argenx, Lundbeck and Takeda are contributing proprietary antibody sequences to a shared dataset aimed at predicting which drug candidates…
Talus skips protein folding to screen 3.4 billion compounds
A Seattle startup says its structure-free model matches drugs to hard targets in milliseconds, sidestepping a blind spot in folding…
A first patient receives Generate’s AI-designed cell therapy for ovarian cancer
Generate Biomedicines and Roswell Park have dosed the first patient with GB-5267, an armored CAR T built with AI to…
DeepMind buries a verifiable marker inside AI-made proteins
Google DeepMind's SynthID Bio hides a detectable signature in AI-designed proteins without changing how they work.
MindRank hands China rights to its AI-designed obesity pill
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal worth up to RMB 1.75B.